The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A Novel Function for Fatty Acid Translocase (FAT)/CD36
Open accessAbstract
Fatty acid translocase (FAT)/CD36 is a long chain fatty acid transporter present at the plasma membrane, as well as in intracellular pools of skeletal muscle. In this study, we assessed the unexpected presence of FAT/CD36 in both subsarcolemmal and intermyofibril fractions of highly purified mitochondria. Functional assessments demonstrated that the mitochondria could bind (14)C-labeled palmitate, but could only oxidize it in the presence of carnitine. However, the addition of sulfo-N-succinimidyl oleate, a known inhibitor of FAT/CD36, resulted in an 87 and 85% reduction of palmitate oxidation in subsarcolemmal and intermyofibril fractions, respectively. Further studies revealed that maximal carnitine palmitoyltransferase I (CPTI) activity in vitro was inhibited by succinimidyl oleate (42 and 48% reduction). Interestingly, CPTI immunoprecipitated with FAT/CD36, indicating a physical pairing. Tissue differences in mitochondrial FAT/CD36 protein follow the same pattern as the capacity for fatty acid oxidation (heart >> red muscle > white muscle). Additionally, chronic stimulation of hindlimb muscles (7 days) increased FAT/CD36 expression and also resulted in a concomitant increase in mitochondrial FAT/CD36 content (46 and 47% increase). Interestingly, with acute electrical stimulation of hindlimb muscles (30 min), FAT/CD36 expression was not altered, but there was an increase in the mitochondrial content of FAT/CD36 compared with the non-stimulated control limb (35 and 37% increase). Together, these data suggest a role for FAT/CD36 in mitochondrial long chain fatty acid uptake and demonstrate system flexibility to match FAT/CD36 mitochondrial content with an increased capacity for fatty acid oxidation, possibly involving translocation of FAT/CD36 to the mitochondria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Febbraio, M., Hajjar, D. P., & Silverstein, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14006 · Cited by 1,193
Fatty acid import into mitochondria
Kerner, J., & Hoppel, C. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00044-5 · Cited by 937
McGarry, J. D., Leatherman, G. F., & Foster, D. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34693-8 · Cited by 600
Tom40 forms the hydrophilic channel of the mitochondrial import pore for preproteins
Hill, K., Model, K., Ryan, M. T., Dietmeier, K., Martin, F., Wagner, R., & Pfanner, N. (1998) · Nature · doi:10.1038/26780 · Cited by 512
The Preprotein Translocation Channel of the Outer Membrane of Mitochondria
Künkele, K.-P., Heins, S., Dembowski, M., Nargang, F. E., Benz, R., Thieffry, M., Walz, J., Lill, R., Nussberger, S., & Neupert, W. (1998) · Cell · doi:10.1016/s0092-8674(00)81206-4 · Cited by 398
Acute Regulation of Fatty Acid Uptake Involves the Cellular Redistribution of Fatty Acid Translocase
Bonen, A., Luiken, J. J. F. P., Arumugam, Y., Glatz, J. F. C., & Tandon, N. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.19.14501 · Cited by 380
Self-citationCogswell, A. M., Stevens, R. J., & Hood, D. A. (1993) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1993.264.2.c383 · Cited by 285
Harmon, C., & Abumrad, N. (1993) · The Journal of Membrane Biology · doi:10.1007/bf00231876 · Cited by 219
Luiken, J. J. F. P., Turcotte, L. P., & Bonen, A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33504-5 · Cited by 202
Self-citationCoort, S. L., Willems, J., Coumans, W. A., Vusse, G. J., Bonen, A., Glatz, J. F. C., & Luiken, J. J. F. P. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020539932353 · Cited by 151
Self-citation
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Metabolic Syndrome and Insulin Resistance: Underlying Causes and Modification by Exercise Training
Roberts, C. K., Hevener, A. L., & Barnard, R. J. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110062 · Cited by 831
Glatz, J. F. C., Luiken, J. J. F. P., & Bonen, A. (2010) · Physiological Reviews · doi:10.1152/physrev.00003.2009 · Cited by 751
Self-citationSkeletal Muscle Lipid Metabolism in Exercise and Insulin Resistance
Kiens, B. (2006) · Physiological Reviews · doi:10.1152/physrev.00023.2004 · Cited by 478
Exercise and Physical Activity: Clinical Outcomes and Applications
Kokkinos, P., & Myers, J. (2010) · Circulation · doi:10.1161/circulationaha.110.948349 · Cited by 444
Talanian, J. L., Galloway, S. D. R., Heigenhauser, G. J. F., Bonen, A., & Spriet, L. L. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01098.2006 · Cited by 441
Self-citationCellular fatty acid uptake: a pathway under construction
Su, X., & Abumrad, N. A. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.11.001 · Cited by 407
AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: implications for obesity.
O’Neill, H. M., Holloway, G. P., & Steinberg, G. R. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.019 · Cited by 364
Fatty acid transport across the cell membrane: Regulation by fatty acid transporters
Schwenk, R. W., Holloway, G. P., Luiken, J. J. F. P., Bonen, A., & Glatz, J. F. C. (2010) · Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA) · doi:10.1016/j.plefa.2010.02.029 · Cited by 318
Self-citationPerry, C. G. R., Heigenhauser, G. J. F., Bonen, A., & Spriet, L. L. (2008) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h08-097 · Cited by 309
“1998, 2000) or mitochondrial membranes (Campbell et al. 2004; Bezaire et al. 2005; Holloway et al. 2006) results in de1120 Appl.”
BackgroundSelf-citationCorpeleijn, E., Saris, W. H. M., & Blaak, E. E. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00544.x · Cited by 280
“FABPc is considered the most important cytosolic protein for guiding LCFAs inside the cell (Fig.”
BackgroundThe role of CD36 in cardiovascular disease
Shu, H., Peng, Y., Hang, W., Nie, J., Zhou, N., & Wang, D. W. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvaa319 · Cited by 277
New Insights into the Interaction of Carbohydrate and Fat Metabolism During Exercise
Spriet, L. L. (2014) · Sports Medicine · doi:10.1007/s40279-014-0154-1 · Cited by 271
CD36 in chronic kidney disease: novel insights and therapeutic opportunities
Yang, X., Okamura, D. M., Lu, X., Chen, Y., Moorhead, J., Varghese, Z., & Ruan, X. Z. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.126 · Cited by 264
Lee, K., Kerner, J., & Hoppel, C. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228692 · Cited by 254
Engin, A. B. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_8 · Cited by 260
Benton, C. R., Nickerson, J. G., Lally, J., Han, X.-X., Holloway, G. P., Glatz, J. F. C., Luiken, J. J. F. P., Graham, T. E., Heikkila, J. J., & Bonen, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m704332200 · Cited by 214
Self-citationSkeletal muscle insulin resistance: roles of fatty acid metabolism and exercise
Turcotte, L. P., & Fisher, J. S. (2008) · Physical Therapy · doi:10.2522/ptj.20080018 · Cited by 209
Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease
Souza-Mello, V. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i8.1012 · Cited by 182
Herbst, E. A. F., Paglialunga, S., Gerling, C., Whitfield, J., Mukai, K., Chabowski, A., Heigenhauser, G. J. F., Spriet, L. L., & Holloway, G. P. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.267336 · Cited by 179
Talanian, J. L., Holloway, G. P., Snook, L. A., Heigenhauser, G. J. F., Bonen, A., & Spriet, L. L. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00073.2010 · Cited by 167
Self-citationRapid exercise-induced changes in PGC-1α mRNA and protein in human skeletal muscle
Mathai, A. S., Bonen, A., Benton, C. R., Robinson, D. L., & Graham, T. E. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00847.2007 · Cited by 158
Self-citationPhysiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Holloway, G. P., Thrush, A. B., Heigenhauser, G. J. F., Tandon, N. N., Dyck, D. J., Bonen, A., & Spriet, L. L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00639.2006 · Cited by 147
Self-citationWatt, M. J., & Hoy, A. J. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00561.2011 · Cited by 142
De Bock, K., Derave, W., Eijnde, B. O., Hesselink, M. K., Koninckx, E., Rose, A. J., Schrauwen, P., Bonen, A., Richter, E. A., & Hespel, P. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01195.2007 · Cited by 144
Self-citationWhitfield, J., Ludzki, A., Heigenhauser, G. J. F., Senden, J. M. G., Verdijk, L. B., van Loon, L. J. C., Spriet, L. L., & Holloway, G. P. (2016) · The Journal of Physiology · doi:10.1113/jp270844 · Cited by 115
Schenk, S., & Horowitz, J. F. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00051.2006 · Cited by 108
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance
Sebastián, D., Herrero, L., Serra, D., Asins, G., & Hegardt, F. G. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2006 · Cited by 89
Wensaas, A. J., Rustan, A. C., Just, M., Berge, R. K., Drevon, C. A., & Gaster, M. (2009) · Diabetes · doi:10.2337/db08-1043 · Cited by 73
Holloway, G. P., Gurd, B. J., Snook, L. A., Lally, J., & Bonen, A. (2010) · Diabetes · doi:10.2337/db09-1519 · Cited by 55
“Differential centrifugation was used to obtain both subsarcolemmal and intermyofibrillar mitochondrial fractions from the red and white portions of the tibialis anterior, as we have previously published (20,31).”
BackgroundMethodSelf-citationYoshida, Y., Jain, S. S., McFarlan, J. T., Snook, L. A., Chabowski, A., & Bonen, A. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238451 · Cited by 55
Self-citationCD36 – A novel molecular target in the neurovascular unit
Ioghen, O., Chițoiu, L., Gherghiceanu, M., Ceafalan, L. C., & Hinescu, M. E. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15147 · Cited by 47
Role of lipid-derived mediators in skeletal muscle insulin resistance
Taube, A., Eckardt, K., & Eckel, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00241.2009 · Cited by 40
“FAT/CD36 suggested that FAT/CD36 is necessary for fatty acid oxidation at the level of the mitochondria (4, 10 , 19).”
BackgroundMethodResultInfluentialA decreased n-6/n-3 ratio in the fat-1 mouse is associated with improved glucose tolerance
Smith, B. K., Holloway, G. P., Reza-Lopez, S., Jeram, S. M., Kang, J. X., & Ma, D. W. L. (2010) · Applied Physiology Nutrition and Metabolism · doi:10.1139/h10-066 · Cited by 35
“All procedures were identical to those previously published by our group (Campbell et al. 2004; Holloway et al. 2009b).”
ResultActivation of AMPKα2 Is Not Required for Mitochondrial FAT/CD36 Accumulation during Exercise
Monaco, C., Whitfield, J., Jain, S. S., Spriet, L. L., Bonen, A., & Holloway, G. P. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126122 · Cited by 27
Self-citation
Metadata
- Authors
- Campbell, S. E., Tandon, N. N., Woldegiorgis, G., Luiken, J. J. F. P., Glatz, J. F. C., & Bonen, A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-08
- Volume
- 279
- Issue
- 35
- Pages
- 36235-36241
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2056761299
- Cited by
- 259
- References
- 26
- FWCI
- 9.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.